What is the name of the new drug developed by scientists recently as an alternative to antibiotics? 

The correct answer is Staphefekt.

Key Points

• Staphefekt
  • It is a proprietary enzyme used to treat Staphylococcus aureus skin infections in humans.
  • It was developed and produced by Micreos, a Dutch biotechnology company.
  • It was the first commercially available endolysin.
  • It is marketed in Gladskin products.
  • The enzyme is effective in killing Staphylococcus aureus strains resistant to antibiotics.
  • It is also successfully used for the treatment of Staphylococcus aureus-related dermatosis.

Additional Information

• Antibiotics
  • It is an antimicrobial substance that is active against bacteria.
  • They are used to treat bacterial infections when prescribed by a health professional.
  • It may either kill or inhibit bacterial growth.
  • Antibiotics are not effective against influenza viruses.
  • The full course of treatment should be completed and should not be saved for future purposes.